We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.83B
AUM Growth
-$23.2M
Cap. Flow
-$201M
Cap. Flow %
-10.94%
Top 10 Hldgs %
24.61%
Holding
261
New
14
Increased
25
Reduced
199
Closed
13

Top Buys

Rank Stock Value
1
SRAD icon
Sportradar
SRAD
+$23.7M
2
FOUR icon
Shift4
FOUR
+$22.6M
3
PRGS icon
Progress Software
PRGS
+$9.32M
4
QDEL icon
QuidelOrtho
QDEL
+$7.08M
5
VRDN icon
Viridian Therapeutics
VRDN
+$6.06M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$58.7M
2
WNS
WNS Holdings
WNS
+$46.2M
3
TKO icon
TKO Group
TKO
+$23.8M
4
WLDN icon
Willdan Group
WLDN
+$8.81M
5
EEFT icon
Euronet Worldwide
EEFT
+$7.12M

Sector Composition

Rank Sector Weight
1 Healthcare 32.04%
2 Technology 28.06%
3 Industrials 17.55%
4 Consumer Discretionary 6.84%
5 Communication Services 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMID icon
176
Smith-Midland
SMID
$152M
$1.72M 0.09%
46,491
-5,252
-10% -$202K
JOUT icon
177
Johnson Outdoors
JOUT
$503M
$1.71M 0.09%
42,302
-17,965
-30% -$670K
CW icon
178
Curtiss-Wright
CW
$25.9B
$1.71M 0.09%
3,146
-28
-0.9% -$13.8K
VICR icon
179
Vicor
VICR
$9.95B
$1.67M 0.09%
33,617
-242
-0.7% -$11.8K
VPG icon
180
Vishay Precision Group
VPG
$884M
$1.6M 0.09%
49,782
-23,121
-32% -$669K
JNJ icon
181
Johnson & Johnson
JNJ
$627B
$1.58M 0.09%
8,538
-11
-0.1% -$1.89K
CLB icon
182
Core Laboratories
CLB
$546M
$1.5M 0.08%
121,451
-57,334
-32% -$672K
BWXT icon
183
BWX Technologies
BWXT
$15.5B
$1.49M 0.08%
8,060
-3,802
-32% -$612K
XYL icon
184
Xylem
XYL
$28.4B
$1.44M 0.08%
9,777
-62
-0.6% -$8.6K
SPB icon
185
Spectrum Brands
SPB
$1.99B
$1.44M 0.08%
+27,351
New +$1.52M
CIEN icon
186
Ciena
CIEN
$56.2B
$1.42M 0.08%
9,763
-66
-0.7% -$6.72K
CLFD icon
187
Clearfield
CLFD
$383M
$1.37M 0.07%
39,809
-18,697
-32% -$696K
VMD icon
188
Viemed Healthcare
VMD
$360M
$1.35M 0.07%
199,401
-39,672
-17% -$269K
VMC icon
189
Vulcan Materials
VMC
$36.7B
$1.34M 0.07%
4,361
-9
-0.2% -$2.56K
LLY icon
190
Eli Lilly
LLY
$1.09T
$1.29M 0.07%
1,690
– –
TNDM icon
191
Tandem Diabetes Care
TNDM
$1.58B
$1.25M 0.07%
102,569
-1,385
-1% -$18.7K
CMRC
192
Commerce.com Inc Series 1
CMRC
$176M
$1.25M 0.07%
249,517
-128,682
-34% -$619K
ABBV icon
193
AbbVie
ABBV
$434B
$1.24M 0.07%
5,359
-57
-1% -$11.6K
NGS icon
194
Natural Gas Services Group
NGS
$480M
$1.24M 0.07%
44,319
-333
-0.7% -$8.53K
BRK.B icon
195
Berkshire Hathaway Class B
BRK.B
$1.14T
$1.23M 0.07%
2,450
– –
PLBC icon
196
Plumas Bancorp
PLBC
$427M
$1.21M 0.07%
27,996
-3,437
-11% -$149K
ON icon
197
ON Semiconductor
ON
$31.5B
$1.18M 0.06%
23,972
-790
-3% -$41.6K
SNBR
198
DELISTED
Sleep Number
SNBR
$1.17M 0.06%
167,378
-12,637
-7% -$111K
MLAB icon
199
Mesa Laboratories
MLAB
$572M
$1.15M 0.06%
17,145
-8,201
-32% -$590K
AZTA icon
200
Azenta
AZTA
$1.53B
$1.14M 0.06%
39,657
-467
-1% -$14.5K
6 7
8
9 10

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Rice Hall James & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Rice Hall James & Associates held 261 positions worth $1.83B, down 1.2% from $1.86B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $201M in Q3 2025, closing 13 positions and reducing 199 holdings. Its most notable exit was Olo Inc, an estimated $4.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Sportradar worth $21.5M.

  • Rice Hall James & Associates's largest Q3 2025 buy was Sportradar: 799,217 shares worth $21.5M.
  • Rice Hall James & Associates added most to Shift4 in Q3 2025, an estimated $22.6M increase.
  • Rice Hall James & Associates's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $58.7M.
  • Rice Hall James & Associates fully exited Olo Inc in Q3 2025, selling an estimated $4.38M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.83B portfolio in Q3 2025.
  • Rice Hall James & Associates opened 14 new positions and closed 13 in Q3 2025.
  • Rice Hall James & Associates's portfolio value fell 1.2% quarter-over-quarter to $1.83B.

Based on Rice Hall James & Associates's 13F filing for Q3 2025, filed 16 Oct 2025.